These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37248914)

  • 1. Sex Differences in Brain Structure in de novo Parkinson's Disease: A Cross-Sectional and Longitudinal Neuroimaging Study.
    Li H; Jia X; Chen M; Jia X; Yang Q
    J Parkinsons Dis; 2023; 13(5):785-795. PubMed ID: 37248914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex effects on brain structure in de novo Parkinson's disease: a multimodal neuroimaging study.
    Tremblay C; Abbasi N; Zeighami Y; Yau Y; Dadar M; Rahayel S; Dagher A
    Brain; 2020 Oct; 143(10):3052-3066. PubMed ID: 32980872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
    Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
    J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in brain atrophy and cognitive impairment in Parkinson's disease patients with and without probable rapid eye movement sleep behavior disorder.
    Oltra J; Segura B; Uribe C; Monté-Rubio GC; Campabadal A; Inguanzo A; Pardo J; Marti MJ; Compta Y; Valldeoriola F; Iranzo A; Junque C
    J Neurol; 2022 Mar; 269(3):1591-1599. PubMed ID: 34345972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor symptoms in Parkinson's disease are related to the interplay between cortical curvature and thickness.
    Almgren H; Hanganu A; Camacho M; Kibreab M; Camicioli R; Ismail Z; Forkert ND; Monchi O
    Neuroimage Clin; 2023; 37():103300. PubMed ID: 36580712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced lateral occipital gray matter volume is associated with physical frailty and cognitive impairment in Parkinson's disease.
    Chen YS; Chen HL; Lu CH; Chen MH; Chou KH; Tsai NW; Yu CC; Chiang PL; Lin WC
    Eur Radiol; 2019 May; 29(5):2659-2668. PubMed ID: 30523452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.
    Dadar M; Zeighami Y; Yau Y; Fereshtehnejad SM; Maranzano J; Postuma RB; Dagher A; Collins DL
    Neuroimage Clin; 2018; 20():892-900. PubMed ID: 30292088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional volumetric change in Parkinson's disease with cognitive decline.
    Gee M; Dukart J; Draganski B; Wayne Martin WR; Emery D; Camicioli R
    J Neurol Sci; 2017 Feb; 373():88-94. PubMed ID: 28131236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
    Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplitude of low-frequency oscillations in Parkinson's disease: a 2-year longitudinal resting-state functional magnetic resonance imaging study.
    Hu XF; Zhang JQ; Jiang XM; Zhou CY; Wei LQ; Yin XT; Li J; Zhang YL; Wang J
    Chin Med J (Engl); 2015 Mar; 128(5):593-601. PubMed ID: 25698189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
    Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
    Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease.
    Sampedro F; Pérez-González R; Martínez-Horta S; Marín-Lahoz J; Pagonabarraga J; Kulisevsky J
    Parkinsonism Relat Disord; 2020 May; 74():43-49. PubMed ID: 32334380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minor hallucinations reflect early gray matter loss and predict subjective cognitive decline in Parkinson's disease.
    Bejr-Kasem H; Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
    Eur J Neurol; 2021 Feb; 28(2):438-447. PubMed ID: 33032389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grey matter atrophy in cognitively impaired Parkinson's disease.
    Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):188-94. PubMed ID: 21890574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive brain atrophy in Parkinson's disease patients who convert to mild cognitive impairment.
    Zhou C; Guan XJ; Guo T; Zeng QL; Gao T; Huang PY; Xuan M; Gu QQ; Xu XJ; Zhang MM
    CNS Neurosci Ther; 2020 Jan; 26(1):117-125. PubMed ID: 31278861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease.
    Xu Y; Yang J; Hu X; Shang H
    J Neurol; 2016 Jun; 263(6):1178-87. PubMed ID: 27113603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis.
    Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Tolosa E; Junque C
    Parkinsonism Relat Disord; 2018 May; 50():3-9. PubMed ID: 29449187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
    González-Redondo R; García-García D; Clavero P; Gasca-Salas C; García-Eulate R; Zubieta JL; Arbizu J; Obeso JA; Rodríguez-Oroz MC
    Brain; 2014 Aug; 137(Pt 8):2356-67. PubMed ID: 24951642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.